Abivax (ABVX) stock surged on Obefazimod trial success and takeover rumors. Learn if valuation risks now outweigh reward.

Privately owned, standalone infusion centers are providing an alternative to hospitals and doctors' offices for patients with ...

Yogurt one staple in so many diets around the world for its deep flavour and creamy texture, along with many health benefits ...

Abivax shares jumped after fresh media reports revived speculation that U.S. drugmaker Eli Lilly is exploring a takeover of the French biotech company.

Johnson & Johnson's portfolio reshaping should enhance margins and long-term growth prospects. Click here to read why JNJ ...

Abivax Presents Third Quarter 2025 Financial Results Cash and cash equivalents of EUR 589.7 (as of September 30, 2025) with a cash runway into Q4 ...

Global specialty, generic and consumer healthcare medicines company STADA and Bio-Thera Solutions (688177:SH), a ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1The decision is supported by the ...

Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD) (OTCQB: DVHGF), today announced operating and financial ...

Under the U.S. Controlled Substances Act, marijuana has been listed as a Schedule ​I substance like heroin, implying it has ...

Zasocitinib is also being evaluated in a head-to-head study against Bristol Myers Squibb’s Sotyktu (deucravacitinib) in ...